Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Nemaura Medical, Inc. (NMRD) had Revenue of $0.08M for the most recently reported fiscal year, ending 2023-03-31.

Quarterly Annual

Figures for fiscal year ending 2023-03-31

Income Statement Financials
Revenue	$0.08M
Net Income	$-14.14M
Cost of Goods Sold	$1.55M
Gross Profit	$-1.48M
Operating Expenses	$9.67M
Operating Income	$-9.60M
Non-Operating Income/Expense	$-4.55M
Pre-Tax Income	$-14.14M
Normalized Pre-Tax Income	$-14.14M
Income after Taxes	$-14.14M
Income from Continuous Operations	$-14.14M
Consolidated Net Income/Loss	$-14.14M
Normalized Income after Taxes	$-14.14M
EBIT	$-9.60M
EBITDA	$-8.17M
Weighted-Average Shares Outstanding (Basic)	24.88M
Weighted-Average Shares Outstanding (Diluted)	24.88M
Earnings per Share (EPS) (Basic)	$-0.57
Earnings per Share (EPS) (Diluted)	$-0.57
Balance Sheet Financials
Current Assets	$13.54M
Property, Plant, and Equipment	$0.64M
Long-Term Assets	$1.03M
Total Assets	$14.56M
Current Liabilities	$22.27M
Long-Term Debt	$3.09M
Long-Term Liabilities	$4.11M
Total Liabilities	$26.38M
Common Equity	$-11.81M
Tangible Shareholders Equity	$-12.20M
Shareholders Equity	$-11.81M
Common Shares Outstanding	28.90M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-8.45M
Cash Flow from Investing Activities	$-0.54M
Cash Flow from Financial Activities	$2.08M
Beginning Cash	$17.75M
End Cash	$10.11M
Increase/Decrease in Cash	$-7.64M
Stock-Based Compensation	--
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.61
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-0.35
Debt to Equity Ratio	-1.70
Gross Margin	-1916.30%
Operating Margin	-12454.23%
EBIT Margin	-12454.23%
EBITDA Margin	-10605.65%
Pre-Tax Profit Margin	-18358.00%
Profit Margin	-18358.00%
Free Cash Flow	$-8.99M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.01
Inventory Turnover	0.89
Receiveable Turnover	0.19
Days Sales in Receivables	1940.73
Return on Equity	119.72%
Return on Tangible Equity	115.95%
Return on Assets	-97.12%
Return on Investments	162.08%
Book Value Per Share	$-0.41
Free Cash Flow per Share	$-0.36
Operating Cash Flow per Share	$-0.34

Data from Zacks Investment Research, Inc.